SECURITIES AND EXCHANGE COMMISSION


                             Washington D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934


                               September 30, 1994
                Date of Report (Date of earliest event reported)


                             ST. JUDE MEDICAL, INC.
               (Exact name of registrant as specified in charter)



        Minnesota                     0-8672                41-1276891       
      (State or other               (Commission           (IRS Employer
        jurisdiction of              File Number)       Identification No.)
        incorporation)



                     One Lillehei Plaza, St. Paul, MN 55117
                    (Address of principal executive offices)(Zip Code)

                                 (612) 483-2000
               Registrant's telephone number including area code

                                 Not applicable
         (Former name or former address, if changed since last report)




ITEM 2.     ACQUISITION OR DISPOSITION OF ASSETS

     Effective September 30, 1994, St. Jude Medical, Inc. acquired substantially
all of the assets (the "Acquisition") of the worldwide cardiac rhythm management
business of Siemens AG, pursuant to two asset purchase agreements: (i) the Asset
Purchase  Agreement dated as of June 26, 1994 among St. Jude Medical,  Inc. (the
"Company"), SJM Acquisition Corp., Siemens-Pacesetter,  Inc. and Siemens Medical
Systems,  Inc. ("SMS") and (ii) the [Non-U.S.] Asset Purchase Agreement dated as
of June  26, 1994 among the Company,  St. Jude Medical  International,  Inc. and
Siemens-Elema AB (collectively, the "Purchase Agreements").

     The   Acquisition   consisted  of  the  tangible  and  intangible   assets,
properties,  rights and  goodwill of  Siemens-Pacesetter,  Inc.  and the Cardiac
Systems Division of Siemens-Elema  AB used in their Cardiac  Stimulation  Device
business,  excluding  cash and certain  other assets.  The principal  production
facilities  acquired are located in Sylmar,  California and Solna,  Sweden, with
sales and support resources in over 70 countries.  The Company presently intends
to  continue  to utilize  the assets  acquired  for the  research,  development,
manufacturing,   marketing  and  sale  of  cardiac  rhythm  management  products
(including technology related to bradycardia,  tachycardia,  atrial fibrillation
and  electrophysiology) in a manner similar to that used by the sellers prior to
the Acquisition.

     In consideration for the Acquisition,  the Company paid $524.3 million,  of
which $13 million was placed into an escrow  account  pending final  adjustments
based on the net book value of the net assets  transferred  to the Company.  The
Company  funded the  Acquisition  through a combination of $274.3 million of its
general funds and $250 million bank debt provided by an eleven-member bank group
lead by Bank of America National Trust and Savings Association. The terms of the
Acquisition were the result of arms-length  negotiation between the parties, and
the Acquisition will be accounted for as a purchase.

     Except for certain  matters  provided  for in the Purchase  Agreements  and
other agreements designed to provide an orderly transition,  it is expected that
the Company and Siemens  will cease to have any  material  contractual  or other
material  relationship  with  each  other  following  the final  purchase  price
adjustment.  The Purchase  Agreements provide that, subject to limitations,  SMS
and  Siemens-Elema  AB will indemnify the Company for certain  losses  resulting
from the  breach  of any of their  representations  and  warranties  and  losses
resulting  from  excluded  liabilities,  and the Company will  indemnify SMS and
Siemens-Elema  AB for certain  losses  resulting from assumed  liabilities.  The
Purchase  agreements  also provide for the  cooperation and access to facilities
and personnel of the parties to assist in matters continuing past closing,  such
as the payment of taxes and  resolution of  outstanding  claims and  litigation.
Other agreements provide for the use of the Siemens name on products, literature
and  tooling  for a  transitional  period,  as  well  as for  the  provision  of
transitional  services  by Siemens in several  foreign  countries  for a limited
period of time.




ITEM 7.     FINANCIAL STATEMENTS, PROFORMA FINANCIAL INFORMATION
            AND EXHIBITS

                (a)     Financial Statements of Business Acquired:

                  At this  time,  it is  impractical  to provide  the  financial
                  statements   of   the   acquired    business.    Pursuant   to
                  paragraph(a)(4)  of  Item  7 of  Form  8-  K,  such  financial
                  statements  will be filed with the Commission no later than 60
                  days after the due date of this  report on Form 8-K  (December
                  16, 1994).

                 (b)     Proforma Financial Information:

                  At this  time,  it is  impractical  to  provide  the  required
                  proforma  financial  information  of  the  acquired  business.
                  Pursuant  to  paragraph  (b)(2)  of Item 7 of Form  8-K,  such
                  proforma   financial   information  will  be  filed  with  the
                  Commission  no later  than 60 days  after the due date of this
                  report on Form 8K (December 16, 1994).

                (c)   Exhibits:

                  2.1  Asset Purchase Agreement dated June 26, 1994.

                  2.2  Non-U.S. Asset Purchase Agreement dated June 26, 1994.


Pursuant to the  requirements  of the  Securities  and Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                               ST. JUDE MEDICAL, INC.



Date                                      By  _________________________________
      
                                                Stephen L. Wilson
                                                Vice President - Finance
                                                and Chief Financial Officer


                                       EXHIBIT INDEX

EXHIBIT
   NO.      DESCRIPTION                                           

2.1         Asset Purchase Agreement among St. Jude Medical, Inc.,
            SJM Acquisition Corp., Siemens-Pacesetter, Inc. and 
            Siemens Medical Systems, Inc. dated as of June 26, 1994.

            Pursuant to Item 601(b)(2) of Regulation S-K, the registrant
            has omitted the following schedules and exhibits and agrees
            to furnish supplementally a copy of any such omitted schedule
            or exhibit to the Commission upon request:

            Schedule 2.2.2 - Adjustments to Closing Balance Sheet
            Schedule 2.2.2.1- Intercompany Eliminations
            Schedule 4.1.3 - Subsidiaries
            Schedule 4.1.5 - Officers and Directors of 
                             Siemens-Pacesetter, Inc.
            Schedule 4.1.6 - Consents
            Schedule 4.1.7 - Defaults
            Schedule 4.2 - Deal Balance Sheet
            Schedule 4.3 - Certain Developments
            Schedule 4.4 - Title to Personal Property and Assets
            Schedule 4.5 - Trademarks, Patents, Patent Applications 
                           and Copyrights
            Schedule 4.6 - Commitments
            Schedule 4.7 - Litigation
            Schedule 4.8 - Permits
            Schedule 4.9 - Governmental Consents, Filings, etc.
            Schedule 4.10 - Employee Benefit Plans
            Schedule 4.11 - Employees
            Schedule 4.12 - Environmental Conditions
            Schedule 4.18 - Insurance
            Schedule 4.19 - Real Property
            Schedule 5.2 - Consents
            Schedule 6.2.2 - Agreements Outside the Ordinary Course
            Schedule 6.10 - Certain Assets
            Schedule 7.3 - Retention Agreements
            Exhibit 3.2.1 - Form of Shareholder Officers' Certificates
            Exhibit 3.2.2 - Form of Opinions of Counsel for 
                            Shareholder and the Company
            Exhibit 3.2.4 - Form of Assignment and Assumption Agreement
            Exhibit 3.2.8A - Form of Bill of Sale and Assignment
            Exhibit 3.2.8B - Form of Deed
            Exhibit 3.2.10 - Form of Canadian Transitional 
                             Services Agreement
            Exhibit 3.3.2 - Form of SJM Officer's Certificate
            Exhibit 3.3.3 - Form of Opinion of Counsel for SJM
            Exhibit 3.3.7 - Form of Assumption Agreement

2.2         [Non-U.S.] Asset Purchase Agreement among St. Jude 
            Medical, Inc., St. Jude Medical Interanational, Inc. and 
            Siemens-Elema AB dated as of June 26, 1994

            Pursuant to Item 601(b)(2) of Regulation S-K, the registrant has
            omitted the following schedules and exhibits and agrees to 
            furnish supplementally a copy of any such omitted schedule or
            exhibit to the Commission upon request:

            Schedule 1.1(a) - Shareholder Affiliates
            Schedule 1.1(a)(i) - Furniture, Fixtures, Equipment, Machinery and
                            Other Tangible Personal Property
            Schedule 1.1(a)(ii) - Vehicles
            Schedule 1.1(a)(iii) - Inventories
            Schedule 1.1(a)(iv) - Accounts Receivable
            Schedule 1.1(a)(viii) - Contracts, Licenses, etc.
            Schedule 1.1(a)(ix) - Intellectual Property
            Schedule 1.1(a)(xiii) - Advances, Deposits, Prepaid Invoices and 
                              Other Prepaid Expenses
            Schedule 1.1(a)(xv) - Interests in Real Property Leases
            Schedule 2.2.2 - Adjustments
            Schedule 2.2.2.1 - Intercompany Eliminations
            Schedule 4.1.4 - Consents
            Schedule 4.1.5 - Defaults
            Schedule 4.2 - Financial Statements
            Schedule 4.3 - Certain Developments
            Schedule 4.4 - Personal Property
            Schedule 4.5 - Patents, Trademarks, Service Marks, 
                           Trade Names, Copyrights; Registrations; 
                           Applications for Registration
            Schedule 4.6 - Commitments
            Schedule 4.7 - Litigation
            Schedule 4.8 - Permits; Consents
            Schedule 4.9 - Governmental Consents
            Schedule 4.10 - Employee Benefit Plans
            Schedule 4.11 - Employees
            Schedule 4.13 - Governmental Notices
            Schedule 4.14 - Real Property
            Schedule 4.17 - Affiliated Transactions
            Schedule 4.18 - Insurance
            Schedule 5.2 - Consents
            Schedule 6.2 - Conduct of Business; Agreements, etc.
            Schedule 7.1.2 - Assumed Employee Benefit Plans
            Schedule 8.5 - Certain Consents
            Exhibit 1.4.1 - Form of Siemens Transitional Services Agreement
            Exhibit 3.2.2 - Form of Assignment and Assumption Agreement